Covid in 2024: The ACTIV Clinical Trials in COVID & Update on COVID-19 and Respiratory Viruses
Dr. Mark W. Geraci and Dr. Graham Snyder present two comprehensive online training sessions, “Covid in 2024: The ACTIV Clinical Trials in COVID” and “Covid in 2024: Update on COVID-19 and Respiratory Viruses.” Designed for healthcare professionals, these sessions will cover the latest in COVID treatment trials, vaccination effectiveness, and strategies to minimize harm from respiratory viruses.
Target Audience
Physician, Advanced Practice Provider, Nurse, Nurse Practitioner, Pharmacist, Physician Assistant, and Other Healthcare Professional.
Learning Objectives
Upon completion of this activity, participants should be able to:
The ACTIV Clinical Trials in COVID - Mark W. Geraci, M
- Define the range of clinical trials for COVID treatment based on the biology of the COVID virus
- Follow the best practices for treatment of COVID based on evidence
- Discuss how viral evolution changed the course of treatment and prevention of COVID
Update on COVID-19 and Respiratory Viruses- Graham Snyder, MD, MS
- Describe the epidemiology of COVID-19, including prevalence, morbidity, and viral ecology of SARS-CoV-2
- Define the effectiveness of COVID-19 vaccination, including the potential clinical benefits of the first seasonal monovalent vaccine
- Discuss how the response to the COVID-19 pandemic may inform approaches to minimizing harm
Presenters (in alphabetical order)
Mark W. Geraci, MD
Associate Vice Chancellor for Interdisciplinary Research, Health Sciences
Vice Dean for Research, School of Medicine
Department of Health Sciences, University of Pittsburgh
Graham Snyder, MD, MS
Medical Director, Infection Prevention & Hospital Epidemiology
Department of Medicine, University of Pittsburgh
CONFLICT OF INTEREST DISCLOSURE
No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
DISCLAIMER STATEMENT
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn ABIM MOC points equivalent to the amount of CME credits claimed for the activity.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Pharmacotherapeutic/pharmacology content contained within each presentation has been calculated and designated in the course agenda. The total hours will be noted on your certificate. Click here for a specific list of the hours awarded for each presentation.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 1.00 AAPA Category I CME
- 1.00 ABIM MOC II
- 1.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 0.25 Pharmacotherapeutic
- 1.00 Attendance
Choose Register/Complete Course to complete the module.
First time Users: If you have never completed training on this website, please select register in the upper right hand corner of the webpage.
Returning Users: If you have completed training on this website, please log in in the upper right hand corner of the webpage.